SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

37

Issue :

2

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

133974024

Full Text :

https://doi.org/10.1200/JCO.18.00131